跳至主要内容
临床试验/jRCT1030260304
jRCT1030260304招募中不适用

A Multi-center, single-blind, Randomized Controlled Trial Comparing Interrupted vs Continuous Fascial Closure in the Mini-laparotomy Incision During Laparoscopic or Robot-assisted Colorectal Resection (CLOSURE-CR trial)

未提供0 个研究点目标入组 900 人开始时间: 待定
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
900

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized

入排标准

年龄范围
18age old over 至 No limit(—)
性别
All

入选标准

  • Patients who meet all of the following inclusion criteria and none of the exclusion criteria will be considered eligible for enrollment.
  • Inclusion Criteria
  • 1.Patients with neoplastic lesions of the colon (including colorectal cancer, appendiceal tumors, neuroendocrine tumors, gastrointestinal stromal tumors, etc.) who are scheduled to undergo curative resection, and for whom laparoscopic or robot-assisted colorectal resection is planned.
  • 2.Patients for whom a small midline laparotomy incision including the umbilicus is planned for bowel transection, anastomosis, and specimen retrieval.
  • 3.Patients with an ECOG Performance Status (PS) of 0, 1, or
  • 4.Patients aged 18 years or older at the time of registration.
  • 5.Patients who are scheduled to undergo an abdominal CT scan at approximately 1 year postoperatively, or for whom such imaging is considered feasible.
  • 6.Patients with preserved function of major organs (including bone marrow, liver, kidney, and lungs) meeting the following criteria:
  • A) White blood cell count: >=2,000mm3 and <=15,000mm3
  • B) Hemoglobin: >=7.5 g/dL
  • C) Platelet count: >=75,000/mm3
  • D) Total bilirubin: <=2.0 mg/dL
  • E) Creatinine: <=2.0 mg/dL
  • 7.Patients who have sufficient capacity to understand the study and have provided written informed consent.

排除标准

  • 1.Patients with umbilical hernia or incisional abdominal wall hernia at the planned umbilical incision site, as identified on preoperative imaging.
  • 2.Patients scheduled to undergo emergency surgery.
  • 3.Patients with active infections requiring systemic treatment.
  • 4.Patients with a body temperature of >=38.0 degrees Celsius at the time of registration.
  • 5.Patients with psychiatric disorders or symptoms that interfere with daily life and are judged to make participation in the study difficult.
  • 6.Women who are pregnant, possibly pregnant, within 28 days postpartum, or breastfeeding.
  • 7.Patients who are scheduled to undergo abdominal surgery within 6 months after registration (e.g., planned surgery for metastatic liver tumors as a staged resection).

研究者

发起方
未提供

相似试验